BaseLaunch
Basel, Basel-Stadtbaselaunch.ch
Overview
BaseLaunch is a Basel-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. It serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operated by Basel Area Business & Innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Engimmune Therapeutics | May 2022 | Seed | Co-investor |
| Cimeio Therapeutics | Apr 2022 | Series A | Co-investor |
| InCephalo Therapeutics | Jun 2021 | Accelerator | Lead |
| PharmaBiome | Jan 2020 | Accelerator | Co-investor |
| Anaveon | Feb 2019 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.